ChemoCentryx

CCXI

CCXI
ChemoCentryx Stock Quote
$60.27 $0.54 0.9%
Price as of May 22, 2020, 8:00 p.m. EDT View Interactive CCXI Charts

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

Interactive Chart


News & Analysis: ChemoCentryx

All

Market Moves

Earnings







Is This Small-Cap Biotech a Buy Before 2020?

Stocks of drug developers, particularly small ones, can skyrocket or crater based on late-stage clinical trials. Before year-end, ChemoCentryx may do one or the other.